Erratum : Late-Onset Immune Checkpoint Inhibitor-Associated Nephrotoxicity and Suspected Thrombotic Microangiopathy Following Durvalumab Administration with a Challenging Clinical Course: A Case Report
Abstract
第52巻 第2号 98頁 右段29行目を次の通り訂正いたします
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Renal Diseases and Glomerulopathies
Acute Kidney Injury Research
Publication details
- Journal / source
- Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
- Volume
- 52
- Issue
- 3
- Pages
- erratum_3–erratum_3
- Publication date
- 24 February 2026
- Language
- EN